Licensing

Vial has a portfolio of wholly owned assets in Oncology, Ophthalmology, I&I, Cardiometabolic, and Rare Diseases - these assets are primarily Antibody (mAb, TCE, bsAb) and RNA treatments (siRNA, ASO).

Interested in licensing one of our assets? Leave us a message and some of your contact info and we’ll be in touch with you shortly.

Licensing

This field is for validation purposes and should be left unchanged.
Name(Required)
By submitting, you are agreeing to our terms and privacy policy